Moraum

[태그:] tissuegene

  • A Turnaround for Kolon TissueGene? The Impact of the Lee Woong-yeol Verdict

    Chairman Lee Woong-yeol has endured a grueling 5-year legal battle, and it’s a relief to see that this chapter has finally come to a close. His brief comment of “Thank you” suggests that this is merely the beginning. While it’s premature to declare that everything is over, as the case could still proceed to the…

  • The Future of Biopharmaceutical a potential Investment Opportunity Korea Bio stocks : Kolon TissueGene

    As we strive for longer and healthier lives, biopharmaceutical companies stand at the forefront of innovation, merging AI and genetic technologies to revolutionize healthcare. This sector holds immense potential for long-term growth, making it an attractive investment opportunity. Global Dividend Trends and Notable Companies: Globally, dividend payout rates have been steadily increasing, with many companies…